Results 81 to 90 of about 20,764 (191)

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.

PLoS ONE, 2017
BackgroundThe antiretroviral drug nevirapine and the antimalarial artemisinin-based combination therapy artemether-lumefantrine are commonly co-administered to treat malaria in the context of HIV.
Liusheng Huang, Vincent Carey, Jane C Lindsey, Florence Marzan, David Gingrich, Bobbie Graham, Linda Barlow-Mosha, Phionah K Ssemambo, Portia Kamthunzi, Sharon Nachman, Sunil Parikh, Francesca T Aweeka, IMPAACT P1079 protocol team   +12 more
doaj   +1 more source

The impact of a Wastewater Treatment Works in Southern Gauteng, South Africa on efavirenz and nevirapine discharges into the aquatic environment

Emerging Contaminants, 2017
There has been growing concern regarding the pollution of the aquatic environment with synthetic organic chemicals. Antiretroviral drugs, such as efavirenz and nevirapine, are pharmaceutical drugs and are referred to as emerging contaminants.
C. Schoeman, M. Dlamini, O.J. Okonkwo
doaj   +1 more source

Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique

, 2010
Aims: Nevirapine is widely used to treat HIV-1 infection to prevent mother-to-child transmission; unfortunately adverse drug reactions have been reported.
Novelli, G, Bramanti, P, PALOMBI, LEONARDO, Paturzo, G, NOVELLI, GIUSEPPE, Palombi, L, Ciccacci, C, Borgiani, P, BORGIANI, PAOLA, Sirianni, E, DORO ALTAN, ANNA MARIA, Doro Altan, AM, Ceffa, S, Marazzi, MC, Sirianni E, Palombi L., Marazzi MC, Paturzo G, BRAMANTI, Placido, Novelli G, Ceffa S, Ciccacci C, Altan AM, Borgiani P, Susanna Ceffa, Cinzia Ciccacci, Elisabetta Sirianni, Placido Bramanti, Paola Borgiani, Maria C Marazzi, Leonardo Palombi, Giuseppe Novelli, Giovanna Paturzo, Anna M Doro Altan   +33 more
core   +1 more source

Nevirapine-induced side effects in pregnant women: experience of a brazilian university hospital

Brazilian Journal of Infectious Diseases
Nevirapine-based therapy is associated with increased frequency of adverse events among HIV-infected pregnant women. The aim of this article was to evaluate the incidence of adverse effects in HIV-infected women who started nevirapine during pregnancy. A
William Kondo, Elaine Aparecida Carraro, Elaine Prandel, Josiane Mourão Dias, Juliane Perini, Rodolfo Lara de Macedo, Taynah Cristina Cornelsen, Renato Sbalquiero, Maria das Graças Sasaki   +8 more
doaj   +1 more source

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

, 2004
In the Declaration of Commitment endorsed during its June 2001 Special Session on HIV/AIDS, the United Nations General Assembly linked the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) with antiretroviral treatment ...
Lallemant, Marc, Bowonwatanuwong, Chureeratana, Hammer, S., Hammer, Scott, Jourdain, Gonzague, Leenasirimakul, P., Kantipong, P., Bowonwatanuwong, C., Ngo-Giang-Huong, Nicole, Le Coeur, Sophie, Leenasirimakul, Prattana, Leechnanachai, P., Kantipong, Pacharee, Ariyadej, S., Leechanachai, Pranee, Ariyadej, Surabhon   +15 more
core   +1 more source

Nelfinavir and nevirapine side effects during pregnancy

, 2005
Background: The risk of vertical transmission of HIV has been substantially reduced since the introduction of highly active antiretroviral therapy (HAART); however, the impact of taking HAART during pregnancy on the woman, the fetus and the infant is not
Timmermans, S, Sprenger, H, Boer, K, Nellen, J, Godfried, MH, Tempelman, C, Schneider, MEE, van der Ende, Marchina E., de Wolf, F   +8 more
core   +3 more sources

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

, 2011
Nevirapine is widely prescribed for HIV-1 infection. We characterized relationships between nevirapine-associated cutaneous and hepatic adverse events and genetic variants among HIV-infected adults. We retrospectively identified cases and controls. Cases
Jing Yuan (217967), Stephen Storfer (16177244), The Nevirapine Toxicogenomics Study Team (16177253), Anna M Cammett (16177238), David Hall (152584), Piroon Mootsikapun (11979900), Supriya Jayadev (69696), Stephen Storfer, Supriya Jayadev, Martin Fisher (300134), David Hall, Daniel Podzamczer, David W Haas, Sheng Guo (143818), David W Haas (16177250), Manuel Distel (16177241), Kiat Ruxrungtham (247724), Sheng Guo, Anna M Cammett, Zimei Huang (16177247), Piroon Mootsikapun, Jing Yuan, Manuel Distel, Kiat Ruxrungtham, Daniel Podzamczer (3211014), Zimei Huang   +25 more
core   +1 more source

Immunovirological treatment out- comes after 2 years of antiretroviral therapy in children living with the human immune deficiency virus in Lagos Nigeria

Nigerian Journal of Paediatrics
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O, Akindele AJ, Akanmu AS, Adeyemi OO   +3 more
doaj  

Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials.

PLoS ONE, 2013
BackgroundNevirapine belongs to the group of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and is commonly administered in first-line treatment of HIV infection.ObjectiveSystematic review and meta-analysis was undertaken to compare ...
Paweł Kawalec, Joanna Kryst, Alicja Mikrut, Andrzej Pilc   +3 more
doaj   +1 more source

Nevirapine induced Stevens-Johnson syndrome: a case report [PDF]

, 2017
Stevens-Johnson syndrome (SJS) is a severe mucocutaneous skin reaction with extensive necrosis and detachment of the epidermis. Nevirapine is one of the high risk agents implicated in development of SJS.
Adiga, Shalini, Patel, Ishan B., Bairy, K. L., Shetty, Disha J.   +3 more
core